IL109234A - History of indole, their preparation and pharmaceutical preparations containing them - Google Patents

History of indole, their preparation and pharmaceutical preparations containing them

Info

Publication number
IL109234A
IL109234A IL109234A IL10923494A IL109234A IL 109234 A IL109234 A IL 109234A IL 109234 A IL109234 A IL 109234A IL 10923494 A IL10923494 A IL 10923494A IL 109234 A IL109234 A IL 109234A
Authority
IL
Israel
Prior art keywords
compound
indole
methoxy
formula
pyridin
Prior art date
Application number
IL109234A
Other languages
English (en)
Hebrew (he)
Other versions
IL109234A0 (en
Original Assignee
Boehringer Ingelheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Italia filed Critical Boehringer Ingelheim Italia
Publication of IL109234A0 publication Critical patent/IL109234A0/xx
Publication of IL109234A publication Critical patent/IL109234A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
IL109234A 1993-04-08 1994-04-06 History of indole, their preparation and pharmaceutical preparations containing them IL109234A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI930699A IT1271352B (it) 1993-04-08 1993-04-08 Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale

Publications (2)

Publication Number Publication Date
IL109234A0 IL109234A0 (en) 1994-07-31
IL109234A true IL109234A (en) 1998-04-05

Family

ID=11365694

Family Applications (1)

Application Number Title Priority Date Filing Date
IL109234A IL109234A (en) 1993-04-08 1994-04-06 History of indole, their preparation and pharmaceutical preparations containing them

Country Status (20)

Country Link
US (1) US5834493A (zh)
EP (1) EP0694033A1 (zh)
JP (1) JPH08508738A (zh)
CN (1) CN1124960A (zh)
AU (1) AU684276B2 (zh)
BG (1) BG100040A (zh)
BR (1) BR9406206A (zh)
CA (1) CA2160020A1 (zh)
CZ (1) CZ283398B6 (zh)
FI (1) FI954734A0 (zh)
HU (1) HUT74090A (zh)
IL (1) IL109234A (zh)
IT (1) IT1271352B (zh)
NO (1) NO953967L (zh)
NZ (1) NZ265055A (zh)
PL (1) PL310995A1 (zh)
SG (1) SG50507A1 (zh)
SK (1) SK119795A3 (zh)
WO (1) WO1994024125A1 (zh)
ZA (1) ZA942383B (zh)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
ES2213897T3 (es) * 1997-05-09 2004-09-01 H. Lundbeck A/S Metodo de fabricacion de sertindol.
US6861448B2 (en) * 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
CA2317439A1 (en) 1998-01-14 1999-07-22 Wayne J. Brouillette Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme
US6673827B1 (en) 1999-06-29 2004-01-06 The Uab Research Foundation Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
US6133287A (en) * 1998-03-24 2000-10-17 Allelix Biopharmaceuticals Inc. Piperidine-indole compounds having 5-HT6 affinity
PT1068184E (pt) * 1998-04-08 2002-12-31 Wyeth Corp Derivados n-ariloxietilamina para o tratamento de depressao
WO1999055697A1 (en) * 1998-04-29 1999-11-04 American Home Products Corporation Serotonergic agents
FR2799463B1 (fr) * 1999-10-12 2004-04-16 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
DE19951360A1 (de) * 1999-10-26 2001-05-03 Aventis Pharma Gmbh Substituierte Indole
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
MXPA03005433A (es) 2000-12-22 2003-09-10 Wyeth Corp Compuestos de heterociclilalquilindol o-azaindol como ligandos de 5-hidroxitriptamina-6.
US7135479B2 (en) 2002-09-12 2006-11-14 Wyeth Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
MX339805B (es) * 2010-04-22 2016-06-10 Intra-Cellular Therapies Inc Compuestos organicos.
MX2014012374A (es) 2012-04-14 2015-04-17 Intra Cellular Therapies Inc Compuestos organicos.
EP2968320B1 (en) 2013-03-15 2020-11-11 Intra-Cellular Therapies, Inc. Organic compounds
KR102495941B1 (ko) 2013-12-03 2023-02-06 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법
RU2016143091A (ru) 2014-04-04 2018-05-08 Интра-Селлулар Терапиз, Инк. Органические соединения
WO2015154025A1 (en) 2014-04-04 2015-10-08 Intra-Cellular Therapies, Inc. Organic compounds
EP3331530A4 (en) * 2015-08-03 2018-12-19 Raze Therapeutics Inc. Mthfd2 inhibitors and uses thereof
AU2017211791B2 (en) 2016-01-26 2022-01-06 Intra-Cellular Therapies, Inc. Organic compounds
DK3407889T3 (da) 2016-03-25 2021-08-09 Intra Cellular Therapies Inc Organiske forbindelser og deres anvendelse til behandling og forebyggelse af lidelser i centralnervesystemet
US10682354B2 (en) 2016-03-28 2020-06-16 Intra-Cellular Therapies, Inc. Compositions and methods
US11331316B2 (en) 2016-10-12 2022-05-17 Intra-Cellular Therapies, Inc. Amorphous solid dispersions
JP6987868B2 (ja) 2016-12-29 2022-01-05 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. 有機化合物
US10961245B2 (en) 2016-12-29 2021-03-30 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
WO2018175969A1 (en) 2017-03-24 2018-09-27 Intra-Cellular Therapies, Inc. Novel compositions and methods
JP7223742B2 (ja) 2017-07-26 2023-02-16 イントラ-セルラー・セラピーズ・インコーポレイテッド 有機化合物
WO2019023063A1 (en) 2017-07-26 2019-01-31 Intra-Cellular Therapies, Inc. ORGANIC COMPOUNDS
EP3843738A4 (en) 2018-08-31 2022-06-01 Intra-Cellular Therapies, Inc. NEW METHODS
EP3843739A4 (en) 2018-08-31 2022-06-01 Intra-Cellular Therapies, Inc. NEW METHODS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
WO1992006973A1 (en) * 1990-10-15 1992-04-30 Pfizer Inc. Indole derivatives
JP3140155B2 (ja) * 1992-03-09 2001-03-05 杏林製薬株式会社 N,n’−ジ置換アミド誘導体
CA2092112A1 (en) * 1992-03-23 1993-09-24 Nobuyoshi Iwata Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use

Also Published As

Publication number Publication date
CA2160020A1 (en) 1994-10-27
ITMI930699A1 (it) 1994-10-08
BG100040A (bg) 1996-03-29
BR9406206A (pt) 1996-02-06
CZ283398B6 (cs) 1998-04-15
NO953967L (no) 1995-12-05
SK119795A3 (en) 1996-04-03
FI954734A (fi) 1995-10-05
ZA942383B (en) 1995-10-09
US5834493A (en) 1998-11-10
IL109234A0 (en) 1994-07-31
WO1994024125A1 (en) 1994-10-27
IT1271352B (it) 1997-05-27
PL310995A1 (en) 1996-01-22
HUT74090A (en) 1996-11-28
EP0694033A1 (en) 1996-01-31
FI954734A0 (fi) 1995-10-05
HU9502913D0 (en) 1995-11-28
JPH08508738A (ja) 1996-09-17
AU684276B2 (en) 1997-12-11
NZ265055A (en) 1996-09-25
NO953967D0 (no) 1995-10-05
AU6538294A (en) 1994-11-08
CN1124960A (zh) 1996-06-19
ITMI930699A0 (it) 1993-04-08
SG50507A1 (en) 1998-07-20
CZ260295A3 (en) 1996-01-17

Similar Documents

Publication Publication Date Title
US5834493A (en) Indole derivatives as 5-HT1A and/or 5-HT2 ligands
JP3057109B2 (ja) 新規インドール誘導体
JPH04506222A (ja) N−置換複素環誘導体およびその製法
JP3165181B2 (ja) 新規の3−アリールインドールおよび3−アリールインダゾール誘導体
JP3834098B2 (ja) ベンゾニトリル類およびベンゾフルオリド類
SK10302001A3 (sk) Piperidínové, tetrahydropyridínové a piperazínové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie
JP2003524571A (ja) インドール−及び2,3−ジヒドロインドール誘導体、その製造方法及びその使用方法
JPH06271571A (ja) インドール、インダゾール及びベンズイソオキサゾール化合物、それらの製法およびそれらを含有する製薬組成物
AU765317B2 (en) 4,5,6 and 7-indole and indoline derivatives, their preparation and use
JP2006502985A (ja) ムスカリン性受容体拮抗剤として有用な3,6−二置換アザビシクロ[3.1.0]ヘキサン誘導体
DE69819903T2 (de) Bicyclische verbindungen als liganden der 5-ht1 rezeptoren
HU224703B1 (en) 2-(3,5-bis-trifluoromethyl-phenyl)-n-methyl-n-(6-morpholin-4-yl-4-0-tolyl-pyridin-3-yl)-isobutyramide, process for producing it, and pharmaceutical compositions containing it
JPH07500353A (ja) 5−ht1アゴニストとしてのインドール誘導体
ZA200700321B (en) Kynurenic acid amide derivatives as NR2B receptor antagonists
JP2006522036A (ja) 精神疾患および神経障害の処置のための5−ht受容体アンタゴニスト
IE63043B1 (en) Cyclic amides
US6066637A (en) Indolyl derivatives as serotonergic agents
JP2006514978A (ja) ムスカリン受容体アンタゴニストである置換アザビシクロヘキサン誘導体
WO1999020621A1 (en) ARYLPIPERAZINES AS SEROTONIN REUPTAKE INHIBITORS AND 5-HT1Dα ANTAGONISTS
JPS6257606B2 (zh)
EP1073651B1 (en) Indolyl derivatives as serotonergic agents
WO2000049017A1 (en) 1-((indoly azacycloalkyl) alkyl)-2,1, 3-benzothiadiazole 2,2-dioxides exhibiting 5-ht2a receptor activity
US6057340A (en) Oxazole derivatives as serotonin-1A receptor agonists
KR101471987B1 (ko) 일정한 cns-관련 질환을 치료하기 위한 2-알킬-인다졸 화합물
US6337336B1 (en) Azaindole derivatives for the treatment of depression

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH Patent void